Sign in
Download Opera News App

STOCK INVESTMENT

Analysts Set Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) Target Price at $4.50

Analysts Set Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) Target Price at $4.50

Shares of Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) have received a consensus rating of “Buy” from the six ratings firms that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year...

Read Full Story
Inc LCTX Lineage Cell Therapeutics NYSEAMERICAN Noble Financial Zacks Investment Research

Top News

US POLITICS

8 Democrats defect on $15 minimum wage hike

politico.com
8 Democrats defect on $15 minimum wage hike

US POLITICS

8 Democrats defect on $15 minimum wage hike

politico.com

US POLITICS

Cuomo aide implicated in nursing home coverup taught 'ethics in government' class

foxnews.com
Cuomo aide implicated in nursing home coverup taught 'ethics in government' class

US POLITICS

Cuomo aide implicated in nursing home coverup taught 'ethics in government' class

foxnews.com

Comments

Load app to read more comments